These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12010652)

  • 1. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
    Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
    Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
    Friedl J; Turner E; Alexander HR
    Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
    Zhang Y; Gu Y; Lucas MJ; Wang Y
    J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway.
    Wyble CW; Hynes KL; Kuchibhotla J; Marcus BC; Hallahan D; Gewertz BL
    J Surg Res; 1997 Dec; 73(2):107-12. PubMed ID: 9441802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells.
    Weber NC; Kandler J; Schlack W; Grueber Y; Frädorf J; Preckel B
    Anesthesiology; 2008 Feb; 108(2):199-207. PubMed ID: 18212564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin.
    Martin TA; Watkins G; Lane J; Jiang WG
    Histopathology; 2005 Apr; 46(4):422-30. PubMed ID: 15810954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
    Martin TA; Mansel R; Jiang WG
    Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.
    Menon C; Ghartey A; Canter R; Feldman M; Fraker DL
    Ann Surg; 2006 Nov; 244(5):781-91. PubMed ID: 17060772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
    Meng D; Liu N
    Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinomenine suppresses TNF-alpha-induced VCAM-1 expression in human umbilical vein endothelial cells.
    Huang J; Lin Z; Luo M; Lu C; Kim MH; Yu B; Gu J
    J Ethnopharmacol; 2007 Nov; 114(2):180-5. PubMed ID: 17869461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.
    Stannard AK; Khurana R; Evans IM; Sofra V; Holmes DI; Zachary I
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):494-502. PubMed ID: 17170373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells.
    Yan W; Tiruppathi C; Qiao R; Lum H; Malik AB
    J Cell Physiol; 1996 Mar; 166(3):561-7. PubMed ID: 8600159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells.
    Eligini S; Barbieri SS; Cavalca V; Camera M; Brambilla M; De Franceschi M; Tremoli E; Colli S
    Cardiovasc Res; 2005 Feb; 65(3):683-93. PubMed ID: 15664395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of TNF-alpha-induced E-selectin expression in endothelial cells via the JNK/NF-kappaB pathways by highly N-acetylated chitooligosaccharides.
    Lin CW; Chen LJ; Lee PL; Lee CI; Lin JC; Chiu JJ
    Biomaterials; 2007 Mar; 28(7):1355-66. PubMed ID: 17126899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells.
    van Rijen HV; van Kempen MJ; Postma S; Jongsma HJ
    Cytokine; 1998 Apr; 10(4):258-64. PubMed ID: 9617570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo.
    Jakob T; Udey MC
    J Immunol; 1998 Apr; 160(8):4067-73. PubMed ID: 9558117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.